Applicant, as named in the Orange Book

Jazz Pharms Res

Jazz Pharmaceuticals plc · Nasdaq: JAZZ

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Next listed expiry: Epidiolex on 24 Sep 2042. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Epidiolex NDA 210365 cannabidiol	cannabidiol	24 Sep 2042 patent, carve-out possible	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.